Enhanced vaccine-induced CD8+ T cell responses to malaria antigen ME-TRAP by fusion to MHC class ii invariant chain.

Enhanced vaccine-induced CD8+ T cell responses to malaria antigen ME-TRAP by fusion to MHC class ii invariant chain.

The orthodox role of the invariant chain (CD74; Ii) is in antigen presentation to CD4+ T cells, but enhanced CD8+ T cells responses have been reported after vaccination with vectored viral vaccines encoding a fusion of Ii to the antigen of interest. In this study we assessed whether fusion of the ma...

Full description

Bibliographic Details
Main Authors:	Alexandra J Spencer, Matthew G Cottingham, Jennifer A Jenks, Rhea J Longley, Stefania Capone, Stefano Colloca, Antonella Folgori, Riccardo Cortese, Alfredo Nicosia, Migena Bregu, Adrian V S Hill
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4063960?pdf=render

Similar Items

Enhanced vaccine-induced CD8+ T cell responses to malaria antigen ME-TRAP by fusion to MHC class ii invariant chain.
by: Spencer, A, et al.
Published: (2014)

Chimpanzee adenoviral vectors as vaccines – challenges to move the technology into the fast lane
by: Alessandra Vitelli, et al.
Published: (2017-12-01)

Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates
by: Capone, S, et al.
Published: (2010)

Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates.
by: Capone, S, et al.
Published: (2010)

MHC class II invariant chain–adjuvanted viral vectored vaccines enhances T cell responses in humans
by: Esposito, I, et al.
Published: (2020)

NEUTRALIZING ANTIBODY TITERS TO SIMIAN ADENOVIRAL VECTORS FOLLOWING ADCH63 ME-TRAP IMMUNIZATION IN HUMANS
by: Goodman, A, et al.
Published: (2009)

Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults.
by: Ogwang, C, et al.
Published: (2013)

Development of a molecular adjuvant to enhance antigen-specific CD8+ T cell responses
by: Halbroth, B, et al.
Published: (2018)

Development of an in vitro assay and demonstration of Plasmodium berghei liver-stage inhibition by TRAP-specific CD8+ T cells.
by: Rhea J Longley, et al.
Published: (2015-01-01)

Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults.
by: Caroline Ogwang, et al.
Published: (2013-01-01)

4-1BBL enhances CD8+ T cell responses induced by vectored vaccines in mice but fails to improve immunogenicity in rhesus macaques.
by: Spencer, A, et al.
Published: (2014)

Evaluation of the Efficacy of ChAd63-MVA Vectored Vaccines Expressing Circumsporozoite Protein and ME-TRAP Against Controlled Human Malaria Infection in Malaria-Naive Individuals.
by: Hodgson, S, et al.
Published: (2014)

Evaluation of the efficacy of chad63-mva vectored vaccines expressing circumsporozoite protein and me-trap against controlled human malaria infection in malaria-naive individuals
by: Hodgson, SH, et al.
Published: (2014)

Fusion of the Mycobacterium tuberculosis antigen 85A to an oligomerization domain enhances its immunogenicity in both mice and non-human primates.
by: Alexandra J Spencer, et al.
Published: (2012-01-01)

Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP
by: Bliss, C, et al.
Published: (2018)

TAPBPR promotes antigen loading on MHC-I molecules using a peptide trap
by: Andrew C. McShan, et al.
Published: (2021-05-01)

Prime-boost vectored malaria vaccines: progress and prospects.
by: Hill, A, et al.
Published: (2010)

Development of an in vitro assay and demonstration of Plasmodium berghei liver-stage inhibition by TRAP-specific CD8+ T cells
by: Longley, R, et al.
Published: (2015)

Comparative assessment of vaccine vectors encoding ten malaria antigens identifies two protective liver-stage candidates.
by: Longley, R, et al.
Published: (2015)

Invariant chain regulation of MHC class II function in the secretory and endocytic pathways
by: Germain, R, et al.
Published: (1997)

Fusion of the Mycobacterium tuberculosis antigen 85A to an oligomerization domain enhances its immunogenicity in both mice and non-human primates.
by: Spencer, A, et al.
Published: (2012)

Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region.
by: Wooldridge, L, et al.
Published: (2007)

IN VIVO ANTIGENIC TARGETS OF T CELLS INDUCED BY ADENOVIRAL VECTORED VACCINES IN PATIENTS WITH CHRONIC HCV INFECTION
by: Kelly, C, et al.
Published: (2012)

A highly immunogenic novel genetic vaccine against HCV
by: Del Sorbo, M, et al.
Published: (2012)

Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations.
by: Kimani, D, et al.
Published: (2014)

Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection
by: Leo Swadling, et al.
Published: (2016-08-01)

Allelic differences affecting invariant chain dependency of MHC class II subunit assembly.
by: Bikoff, E, et al.
Published: (1995)

MHC class II-associated invariant chain isoforms regulate pulmonary immune responses.
by: Ye, Q, et al.
Published: (2003)

Exposing the specific roles of the invariant chain isoforms in shaping the MHC class II peptidome
by: Jean-Simon eFortin, et al.
Published: (2013-12-01)

A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya
by: Bejon, P, et al.
Published: (2006)

Mucosal Vaccination with Heterologous Viral Vectored Vaccine Targeting Subdominant SIV Accessory Antigens Strongly Inhibits Early Viral Replication
by: Huanbin Xu, et al.
Published: (2017-04-01)

Enhancing blood-stage malaria subunit vaccine immunogenicity in rhesus macaques by combining adenovirus, poxvirus, and protein-in-adjuvant vaccines.
by: Draper, S, et al.
Published: (2010)

An in vitro T cell killing assay to assess new Plasmodium falciparum vaccine candidates
by: Longley, R, et al.
Published: (2013)

Antiviral immune responses of mice lacking MHC class II or its associated invariant chain.
by: Battegay, M, et al.
Published: (1996)

In vivo functions mediated by the p41 isoform of the MHC class II-associated invariant chain.
by: Takaesu, N, et al.
Published: (1997)

Association with BiP and aggregation of class II MHC molecules synthesized in the absence of invariant chain.
by: Bonnerot, C, et al.
Published: (1994)

MHC class II expression in double mutant mice lacking invariant chain and DM functions.
by: Kenty, G, et al.
Published: (1998)

PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES
by: Folgori, A, et al.
Published: (2009)

Identification of Immunodominant Responses to the Plasmodium falciparum Antigens PfUIS3, PfLSA1 and PfLSAP2 in Multiple Strains of Mice.
by: Rhea J Longley, et al.
Published: (2015-01-01)

Extended Follow-Up Following a Phase 2b Randomized Trial of the Candidate Malaria Vaccines FP9 ME-TRAP and MVA ME-TRAP among Children in Kenya
by: Bejon, P, et al.
Published: (2007)